Tag: drye eye syndrome

November 28, 2017 Off

TopiVert’s study with consistent effects on dry eye syndrome

TopiVert Pharma, a clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for chronic inflammatory gastrointestinal (GI) and ocular diseases,…

February 22, 2017 Off

TopiVert’s gives dry eye syndrome candidate to first patient, waits results in second half of 2017

By Dino Mustafić

A UK-based private clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for the treatment of chronic inflammatory gastrointestinal (GI) and ocular diseases, has triggered the phase 1/2a proof of concept study in the US of TOP1630 ophthalmic solution for the treatment of the dry eye syndrome.